Abstract Details
|
Ahmed Enayetallah, PhD, MBBCh
(BlueRock Therapeutics)
PRESENTER |
Dr. Enayetallah has received personal compensation for serving as an employee of Alexion. Dr. Enayetallah has received stock or an ownership interest from Alexion. Dr. Enayetallah has received stock or an ownership interest from AstraZeneca. |
| No disclosure on file | |
| Richard M. Ransohoff, MD (Third Rock Ventures) | Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care. |
| Jaya Goyal | No disclosure on file |